Company page

Cellromax Science Co., Ltd.

Cellromax Science Co., Ltd. is a public company traded under the ticker 471820 on the Korean market. The company has a market capitalization of approximately 34.3 million USD. Cellromax focuses on developing innovative solutions in its industry, contributing to advancements in technology and science.

profile471820AI content: aiUpdated May 30, 2026/company/cellromax-science-co-ltd
Cellromax Science Co., Ltd. logo
Ticker
471820
Market cap
$34.3M
Sector
Health Technology
Industry
Pharmaceuticals: Other